Aliquoting Peptide Solutions: Vials, Volumes and Avoiding Contamination

Aliquoting peptide solutions solves one problem — the parent vial is entered once and never again — and it trades a small, calculable transfer loss for the elimination of repeated freeze–thaw damage, cumulative septum punctures and single-point-of-failure risk. The decision is not automatic: below roughly 100 µL, adsorption to container surfaces starts to cost more peptide than freeze–thaw would have. This guide covers when to split a stock and when not to, the procedure, the arithmetic of transfer losses, and the container choices that make the difference. It concerns handling of laboratory reference solutions for research use only.

Four reasons for aliquoting peptide solutions

1. Freeze–thaw damage. Each freezing round concentrates solutes at the advancing ice front and creates a large ice–water interface. Both drive aggregation and, for disulfide-bonded peptides, scrambling. Published stability work on peptide and protein solutions commonly reports measurable loss after three to five rounds, with the exact number depending heavily on sequence and buffer. An aliquot is thawed once.
2. Septum integrity. A rubber stopper tolerates a limited number of punctures before coring debris and leak paths appear. A stock drawn from twenty times has been punctured twenty times; a stock split once has been punctured once.
3. Contamination containment. If one aliquot is compromised, you lose that aliquot. If the parent vial is compromised on entry fifteen, you lose everything and cannot tell which earlier experiments were affected.
4. Traceability. Aliquots can be dated and labelled individually, so a result maps to a specific container rather than to "the vial, sometime in March".

When not to aliquot

• Very small volumes. Peptides adsorb to glass and plastic surfaces. Loss scales with surface-area-to-volume ratio, which rises sharply as volume falls. A 50 µL aliquot in a standard vial can lose a substantial percentage of a dilute peptide to the walls; the same solution in bulk loses a negligible fraction.
• Dilute solutions without a carrier. Below roughly 10 µg/mL, adsorption becomes the dominant loss route regardless of volume. Low-bind containers or a carrier protein such as 0.1% BSA mitigate it — but BSA interferes with protein assays and some immunoassays, so it is a design decision rather than a default.
• Short working lifetimes. A solution that will be consumed within a week refrigerated gains nothing from being split into freezer aliquots.
• When the transfer itself is the risk. Every transfer is an opportunity to introduce contamination or a pipetting error. If a stock will be entered only two or three times, the parent vial is the safer container.

Worked example: splitting a 10 mg vial

1. Reconstitute. 10 mg with 4 mL of bacteriostatic water → 10 ÷ 4 = 2.5 mg/mL.
2. Choose the split. Eight aliquots of 0.5 mL each. Each holds 0.5 × 2.5 = 1.25 mg of peptide, or 1,250 mcg.
3. Count the transfer loss. Using a fixed-needle insulin syringe with roughly 3 µL of dead space, eight transfers strand 8 × 3 = 24 µL. Against 4,000 µL that is 0.6%, or about 60 mcg across the whole vial.
4. Compare a detachable-needle syringe. At 80 µL of dead space per transfer, the same eight aliquots lose 640 µL — 16%, or 1.6 mg of a 10 mg vial. The syringe choice is worth more than the aliquoting decision itself.
5. Fill volume per container. A 3 mL vial holding 0.5 mL is filled to about one sixth of capacity, leaving ample headspace for the roughly 9% volume expansion when aqueous solution freezes. Never fill a container to be frozen past about two thirds.
6. Cross-check the maths. 8 × 1.25 mg = 10 mg, less 0.6% transfer loss ≈ 9.94 mg accounted for.

Choosing the aliquot size

The practical rule: pick the volume that matches one working session, then check that it is not below 100 µL. Splitting finer than your actual usage pattern adds transfers, adds surfaces and adds nothing.

Procedure

1. Reconstitute the parent vial gently — diluent down the vial wall, swirl rather than shake, no vortexing. The full method is in the reconstitution guide.
2. Let the cake dissolve completely before transferring anything. Aliquoting a partially dissolved solution distributes concentration unevenly across containers, and that error is undetectable afterwards.
3. Label the receiving containers first. Peptide name, concentration in mg/mL, volume, date, lot number. Vial labels and log sheets exist for this; labelling after filling is how aliquots become anonymous.
4. Wipe every septum with an alcohol prep pad and let it dry.
5. Transfer with a fixed-needle syringe such as the 31G insulin syringe, into pre-sterilised sterile empty vials. Change the needle if you touch anything other than the two septa.
6. Work at a consistent volume. Draw to the same mark each time rather than dividing what is left; the last aliquot absorbs all accumulated error otherwise.
7. Freeze upright and promptly. Rapid freezing gives smaller ice crystals and a smaller interfacial area.
8. Record the split — parent lot, concentration, number and volume of aliquots, date, storage location.

Sterility during the split

Reconstitution and aliquoting are not sterile procedures unless performed in a laminar-flow cabinet. Bacteriostatic water's 0.9% benzyl alcohol inhibits growth but does not sterilise, and it does nothing about particulates. When a downstream application requires a sterile solution, filtering through a 0.22 µm syringe filter into pre-sterilised vials is the standard approach, since heat sterilisation destroys peptides. Expect a small adsorptive loss on the membrane, and pre-rinse the filter with diluent when working at low concentration.

Common mistakes

• Aliquoting before the cake has fully dissolved, producing containers at different real concentrations.
• Filling containers too full to freeze — aqueous solution expands about 9% and will pop a stopper or crack glass.
• Using a detachable-needle syringe, quietly losing 15% of the vial to hub dead space.
• Splitting into volumes smaller than the working session, so aliquots get refrozen anyway and the entire benefit is lost.
• Labelling with the peptide name only. Without concentration, date and lot, an aliquot cannot support a result.
• Re-pooling leftovers from several thawed aliquots back into one container, which combines the freeze–thaw history of all of them.

Storage temperatures and expected working lifetimes for the resulting aliquots are covered in how to store peptides; the errors this procedure is designed to avoid are listed in common reconstitution and storage mistakes. Containers and consumables sit in reconstitution supplies.